In late 2020, then-HHS Secretary Alex Azar tapped Berkeley, California-based Cogitativo to help inform the Trump Administration's vaccine distribution strategy. The company had developed a machine learning model that could predict the probability a patient would end up in an intensive care unit bed. Using 60 million records from HHS, Cogitativo created risk scores that flagged individuals who might be at particular risk from the effects of COVID-19. Now, explained CEO Gary Velasquez, the company has been tasked with a new project: Working with the Veterans Health Administration to identify beneficiaries who have deferred care during COVID-19. At this point, said Velasquez in an interview with Healthcare IT News, "You're worried about the veterans you haven't seen."

Information contained on this page is provided by an independent third-party content provider. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com Cogitativo, Inc., the first-to-market machine learning and data-science-as-a-service company for healthcare organizations, announced today the closing of a $5 million Series A funding round. The strategic investment by HCSC Ventures, Inc., a wholly-owned subsidiary of Health Care Service Corporation which specializes in investments in innovative health care companies, will support the product-line expansion for anomaly detection and real-time operational decision support solutions for healthcare payers. Cogitativo brings a new scientific paradigm to the rapidly growing market for healthcare performance improvements by enabling payers and providers to challenge system complexity through Cogitativo's machine learning platform. Cogitativo has more than tripled in size over the past two years while introducing new disruptive, machine learning products in areas of payment integrity and anomaly detection.